69 Best Engineering Startups to Watch in 2024

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Total Raised: $1018.00M

Last Funding: $1000.00M (Series D)

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Total Raised: $1000.00M

Last Funding: $1000.00M (Series D)

Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Total Raised: $313.00M

Last Funding: $18.00M (Unknown)

Machine learning platform for data scientists and engineers to help create enterprise AI.

Total Raised: $746.63M

Last Funding: $400.00M (Series E)

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

Total Raised: $66.00M

Last Funding: $41.00M (Series E)

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Total Raised: $111.00M

Last Funding: $68.00M (Series D)

Protembis is a cerebral Protection System founded in 2013.

Total Raised: $64.67M

Last Funding: $21.67M (Debt Financing)

ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.

Total Raised: $205.00M

Last Funding: $205.00M (Series D)

Cytovale is a company that develops biomarkers based on the mechanical properties of cells to identify diseases. It has applied its technology to detect sepsis.

Total Raised: $119.30M

Last Funding: $100.00M (Series D)

ZAP Surgical Systems designs and manufactures the ZAP-X® radiosurgery platform.

Total Raised: $159.00M

Last Funding: $78.00M (Series E)

Small molecule MKK4 inhibitors to treat acute and chronic liver diseases

Total Raised: $37.60M

Last Funding: $16.00M (Series C)

Lumicks is a drug discovery platform for cancer founded in 2014 by Gerrit Sitters .

Total Raised: $114.90M

Last Funding: $21.90M (Debt Financing)

Inbrain Neuroelectronics is a developer of brain-computer interface therapeutics (BCI-Tx founded in 2020 by Carolina Aguilar.

Total Raised: $68.10M

Last Funding: $50.00M (Series B)

Paebbl is a carbon-storing building materials manufacturer founded in 2021 by Pol Knops, Marta Sjögren and Andreas Saari.

Total Raised: $25.00M

Last Funding: $25.00M (Series A)

InterVene is an up and coming medical device start-up company reinventing the way physicians treat severe venous disease in the legs.

Total Raised: $28.00M

Last Funding: $13.00M (Series A)

Okami Medical develops and commercializes new devices for the treatment of heart disease.

Total Raised: $39.70M

Last Funding: $32.50M (Unknown)

Centaur Labs is a medical AI platform that offers medical data labeling services.

Total Raised: $16.15M

Last Funding: $16.00M (Series B)

TCR-based immunotherapies developer targeting novel dark antigens for cancer patients.

Total Raised: $32.50M

Last Funding: $32.50M (Series B)

Human genome sequencing company founded in 2013 and based in San Diego, CA. Human Longevity Inc. is building a database with genomic and phenotypic information and aims to make medicine more data-driven by combining DNA sequencing, expert analysis and machine learning

Total Raised: $39.80M

Last Funding: $39.80M (Series B)

Cerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.

Total Raised: $59.50M

Last Funding: $11.00M (Series D)

Platform for scientists to gain new insights in spatial biology using Molecular Cartography.

Total Raised: $95.00M

Last Funding: $71.00M (Series B)

Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.

Total Raised: $16.00M

Last Funding: $16.00M (Seed)

Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.

Total Raised: $9.00M

Last Funding: $9.00M (Seed)

AltraTech is a next-generation molecular detection technology developer founded in 2013 by Tim Cummins.

Total Raised: $11.50M

Last Funding: $11.50M (Series A)

SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.

Total Raised: $52.81M

Last Funding: $52.81M (Series A)

Immatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.

Total Raised: $180.09M

Last Funding: $58.00M (Series E)

Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.

Total Raised: $183.00M

Last Funding: $47.50M (Unknown)

A healthcare technology company offering a cloud-based molecular profiling platform.

Total Raised: $250.80M

Last Funding: $250.80M (Series A)

Atonarp is a Tokyo-based electronics and data processing manufacturer developing spectrometers capable of gas-composition analysis.

Total Raised: $83.00M

Last Funding: $50.00M (Series D)

Dessia is an AI-powered generative engineering software solutions provider founded in 2017 by Pierre Emmanuel Dumouchel.

Total Raised: $3.30M

Last Funding: $3.30M (Series A)

Uncommon, formerly known as Higher Steaks, is a cellular agriculture company based in London, England founded in 2017 by Benjamina Bollag, Stephanie Wallis and David Hay working to develop pork and other meat products using cellular agriculture.

Total Raised: $30.00M

Last Funding: $30.00M (Series A)

A company developing therapeutics for acute inflammatory central nervous system conditions

Total Raised: $24.30M

Last Funding: $6.50M (Series F)

Tubulis Therapeutics is a Munich-based therapeutics company developing matched protein-drug conjugates.

Total Raised: $75.30M

Last Funding: $63.00M (Series B)

Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine.

Total Raised: $83.17M

Last Funding: $3.70M (Seed)

Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates.

Total Raised: $2.50M

Last Funding: $2.50M (Unknown)

Provider of SITESEEKER platform for discovering new drugs.

Total Raised: $64.80M

Last Funding: $46.00M (Series B)

Small Molecules based on Omega-3 Fatty acid metabolites

Total Raised: $34.90M

Last Funding: $19.40M (Series C)

ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.

Total Raised: $36.20M

Last Funding: $36.20M (Unknown)

NantHealth is a Culver City, California-based company providing an evidence-based platform for healthcare diagnostics.

Total Raised: $100.00M

Last Funding: $75.00M (Unknown)

ThinkCyte is a company focusing on image-activated cell sorting.

Total Raised: $26.00M

Last Funding: $26.00M (Series B)

Adrenomed is a sepsis drug.

Total Raised: $26.30M

Last Funding: $26.30M (Series E)

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

Total Raised: $91.70M

Last Funding: $75.30M (Series B)

SOPHiA GENETICS is a healthcare technology company and developer of SOPHiA Artificial Intelligence for clinical genomics.

Total Raised: $110.00M

Last Funding: $110.00M (Unknown)

Immunocore Limited is a biotechnology research company based in Abingdon, Oxfordshire focused on developing therapies for the treatment of cancer.

Total Raised: $75.00M

Last Funding: $75.00M (Series C)

Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005.

Total Raised: $43.00M

Last Funding: $43.00M (Series A)

iOmx Therapeutics is a cancer Immunotherapy founded in 2016.

Total Raised: $75.26M

Last Funding: $75.26M (Series B)

Theseus Pharmaceuticals is a kinase Inhibitors founded by Wei-Sheng Huang.

Total Raised: $100.00M

Last Funding: $100.00M (Series B)

CENTOGENE is a Rostock-based healthcare company developing methods and technologies for genetics analysis.

Total Raised: $28.00M

Last Funding: $28.00M (Series A)

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Total Raised: $88.00M

Last Funding: $88.00M (Series D)

Hummingbird Diagnostics is an Heidelberg-based molecular diagnostics company developing liquid biopsy technology for early disease detection, personalized medicine, and lifetime monitoring of disease-specific biomarkers founded in 2017 by Ryan Gerard, Jesse Reiss, JoAnn Barefoot, Matthew Van Buskirk and Joe Robinson.

Total Raised: $8.20M

Last Funding: $8.20M (Series A)

Topas Therapeutics is a nanoparticles loaded with Antigenic Peptides.

Total Raised: $48.00M

Last Funding: $48.00M (Series B)

Hifibio - High Fidelity Biology is a single cell technologies for drug discovery founded in 2013 by Liang Schweizer, Jeff He and Robert Nicol.

Total Raised: $75.00M

Last Funding: $75.00M (Series D)

Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.

Total Raised: $56.00M

Last Funding: $56.00M (Series B)

GeneQuine Biotherapeutics GmbH is a German based biotechnology company that was founded in 2011

Total Raised: $9.88M

Last Funding: $3.37M (Unknown)

Product management system aiding organizations in getting products to market faster.

Total Raised: $45.00M

Last Funding: $45.00M (Unknown)

CND Life Sciences, Inc. is a synucleinopathy Diagnostic founded in 2017.

Total Raised: $7.50M

Last Funding: $2.50M (Unknown)

Lysogene is a company by Karen Aiach.

Total Raised: $16.50M

Last Funding: $16.50M (Series A)

Tacalyx is an antibodies for cancer founded in 2019.

Total Raised: $7.70M

Last Funding: $7.70M (Seed)

ActiTexx is a biotechnology company founded in 2020.

Total Raised: $4.20M

Last Funding: $4.20M (Series A)

Sample prep for proteins, peptides and proteomic analysis by MS

Total Raised: $3.80M

Last Funding: $3.80M (Series A)

Pantherna Therapeutics is a nanoparticle Delivery for mRNA drugs.

Total Raised: $3.90M

Last Funding: $3.90M (Seed)

Research and development of innovative cancer treatments using protein nanoparticles for clinical phases.

Total Raised: $1.13M

Last Funding: $1.13M (Seed)

Nostos Genomics is an AI-driven deciphering of genetic diseases founded in 2018 by David Gorgan.

Total Raised: $5.70M

Last Funding: $5.70M (Seed)

A software solutions company providing bioinformatics solutions to life science and other sector

Total Raised: $12.64M

Last Funding: $3.64M (Seed)

GNA Biosolutions is a Martinsried-based molecular diagnostics company.

Total Raised: $13.50M

Last Funding: $13.50M (Series C)

LenioBio is a cell-free protein expression kit founded in 2016.

Total Raised: $13.00M

Last Funding: $13.00M (Series A)

Carl Zeiss Meditec is a medical Devices founded in 2002 by Carl Zeiss.

Total Raised: $1.90M

Last Funding: $1.90M (Seed)

VisionGate is a Phoenix, Arizona-based in-vitro Automated 3D Cell Structure and Analysis founded in 2001 by Alan Nelson.

Total Raised: $2.00M

Last Funding: $2.00M (Unknown)

codeSpark is a company founded in 2014.

Total Raised: $2.50M

Last Funding: $2.50M (Seed)